VPAResearch
VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.
Research Reports By VPAResearch
Found 3385 publications
2019 Hemophilia A R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 120 pages
2019 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Toxoplasmosis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Yellow Fever R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 55 pages
2019 Human herpesvirus 4(HHV-4) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 90 pages
2019 Botulism R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Chlamydia Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Impetigo R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 30 pages
2019 Streptococcus pyogenes Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 45 pages
2019 Fanconi Anemia R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 52 pages
2019 Leishmaniasis (Kala-Azar) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 100 pages
2019 Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 45 pages
2019 Hepatitis E R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 30 pages
2019 Neutropenia R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 70 pages
2019 Rotavirus Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Cryptococcosis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Influenza B virus Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 95 pages
2019 Hand-Foot-Mouth Disease R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Meningitis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 30 pages
2019 Tinea pedis (Athlete Foot) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Western Equine Encephalitis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 35 pages
2019 Hospital Acquired Pneumonia (HAP) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 75 pages
2019 Bacterial Vaginosis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Pertussis (Whooping Cough) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 72 pages
2019 Chikungunya Fever R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 80 pages
2019 Immune Thrombocytopenic Purpura R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 82 pages
2019 Pyelonephritis R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 55 pages
2019 Smallpox R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Epstein–Barr Virus (EBV) Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 90 pages
2019 Lassa Fever (Lassa Hemorrhagic Fever) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 53 pages
2019 Neisseria meningitidis Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 65 pages
2019 Vancomycin-Resistant Enterococcus faecium Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 69 pages
2019 Hepatitis D(HDV) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Anemia in Chronic Kidney Disease (Renal Anemia) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 86 pages
2019 Influenza A Virus, H7N9 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 64 pages
2019 Rhinovirus Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 51 pages
2019 Community Acquired Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 70 pages
2019 Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 30 pages
2019 Haemophilus influenzae Type B Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 60 pages
2019 Measles (rubeola) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 West Nile Virus Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 50 pages
2019 Herpes Zoster (Shingles) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 45 pages
2019 Bacillary Dysentery (Shigellosis) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 40 pages
2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 65 pages
2019 Pseudomonas aeruginosa Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 35 pages
2019 Chagas Disease (American Trypanosomiasis) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 65 pages
2019 Idiopathic Thrombocytopenic Purpura (ITP) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
Mar, 2019 82 pages
